Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces حسب Guangchao Han (1453198)

الموضوعات:

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces حسب Guangchao Han (1453198)

الموضوعات:

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces حسب Guangchao Han (1453198)

الموضوعات:

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces حسب Guangchao Han (1453198)

الموضوعات:

Measurement of the mitochondrial superoxide anion production in HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. حسب Patrick Mordel (17020879)

Comparison of oxidized proteins extracted from HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. حسب Patrick Mordel (17020879)

Effectiveness of interventions to decrease hesitancy. حسب Maximilian Nicolaus Burger (12969212)

Distribution Coefficients of the REEs, Sr, Y, Ba, Th, and U between α‑HIBA and AG50W-X8 Resin حسب Haoyu Li (1672648)

"…However, only limited REE partition data between α-HIBA and cation resins exist, which makes it challenging to develop and optimize purification techniques using this platform. Here, we report distribution coefficients (<i>K</i>_d) of REEs, as well as Sr, Y, Ba, Th, and U, between α-HIBA at pH = 4.50 and AG50W-X8 cation-exchange resin, obtained by batch equilibration experiments. …"

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. حسب Hakim Ben Abdallah (14578241)

Prediction of the effect of the 9 nsSNPs on AKT2 proteins’ structure and function by eight computational tools. حسب Sadia Afrin Runa (22504971)

Demographics and baseline characteristics of the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. حسب Rahsan Erdem (11726357)

الموضوعات:

Grading of stool consistency and diarrhea severity. حسب Rahsan Erdem (11726357)

الموضوعات:

Secondary efficacy endpoints for the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 1. حسب Rahsan Erdem (11726357)

الموضوعات:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for S1 and S2 Figs. حسب Rahsan Erdem (11726357)

الموضوعات:

Source data for Fig 2. حسب Rahsan Erdem (11726357)

الموضوعات:

Consolidated Standards for Reporting of Trials flow diagram. حسب Rahsan Erdem (11726357)

الموضوعات: